What does CUSIP 89620X956 represent in this 13F holders report?

CUSIP 89620X956 is the security identifier for 89620X956 - TRILLIUM THERAPEUTICS INC - COM NEW - Put used to aggregate holder disclosures.

How many institutions held 89620X956 - TRILLIUM THERAPEUTICS INC - COM NEW - Put in Q2 2021?

No institutional holders were reported for 89620X956 - TRILLIUM THERAPEUTICS INC - COM NEW - Put in Q2 2021; review adjacent reporting periods for trend context.

TRILLIUM THERAPEUTICS INC - COM NEW - Put

CUSIP: 89620X956

Q2 2021 13F Holders as of 30 Jun 2021

Type / Class: Equity / COM NEW
Price per share: $9.69
Number of holders: 0

Quarterly Holders Quick Answers

What is CUSIP 89620X956?
CUSIP 89620X956 identifies 89620X956 - TRILLIUM THERAPEUTICS INC - COM NEW - Put in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Related Filing Research

Latest 13F filings for newly reported positions.
Latest Schedule 13D/13G reports for ownership changes outside 13F cadence.
Latest 10-Q/10-K reports for financial context tied to this issuer.
Recent insider transactions for executive and insider activity.
SEC investors directory and top value investors for manager drilldown.
Back to full security ownership history.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q3 2021
Previous quarter: Q1 2021

Recent filing periods for CUSIP 89620X956:

Q4 2021 Q3 2021 Q2 2021 Q1 2021 Q4 2020 Q3 2020 Q2 2020 Q1 2020

TRILLIUM THERAPEUTICS INC - COM NEW - Put

Q2 2021 13F Holders as of 30 Jun 2021

Quarterly Holders Quick Answers

Related Filing Research

Explore More Reporting Periods

There are no holders of TRILLIUM THERAPEUTICS INC - COM NEW - Put as of Q2 2021.